NCT00654303View on ClinicalTrials.gov

OLE Study to Evaluate Safety / Efficacy of ZD4522

PHASE3CompletedINTERVENTIONAL

Enrollment

3,500

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

February 28, 2005

Conditions

Hypercholesterolaemia

Interventions

DRUG

Rosuvastatin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY